Infection Surveillance Solutions Market Size

  • Report ID: 6444
  • Published Date: Sep 17, 2024
  • Report Format: PDF, PPT

Infection Surveillance Solutions Market Size

Infection Surveillance Solutions Market size is assessed at USD 681.9 million in 2024 and is set to cross USD 3.4 billion by the end of 2037, witnessing more than 14.3% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of infection surveillance solutions is evaluated at USD 779.4 million.

The primary growth driver for the infection surveillance solutions market is the increasing prevalence of infectious diseases and the rising awareness of infection control in healthcare settings.  This includes the need for effective monitoring and tracking of infections to improve patient outcomes, prevent outbreaks, and enhance overall healthcare quality. According to the Department of Biotechnology, Ministry of Science and Technology, Government of India, infectious diseases are among the top ten causes of death in the country, led by diarrheal diseases, neonatal disorders, lower respiratory infections, and tuberculosis.

The infection surveillance solutions market is also expanding due to an increase in hospital-acquired infections (HAIs). According to the World Health Organization (WHO), HAIs impact one out of every ten patients on average. However, in low- and middle-income nations, as well as among high-risk patients in intensive care units, the frequency may be much higher.


Infection Surveillance Solutions Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6444
  • Published Date: Sep 17, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of infection surveillance solutions was over USD 681.9 million.

The market size for infection surveillance solutions is projected to cross USD 3.4 billion by the end of 2037 expanding at a CAGR of 14.3% during the forecast period i.e., between 2025-2037.

The major players in the market are Gojo Industries, Inc., Premier, Inc., Wolters Kluwer N.V., Deb Group Ltd., BioVigil Healthcare Systems, Vecna Technologies, Inc., Pfizer Inc., Inovalon, Baxter International Inc., Cerner Corporation, and others.

The software segment is anticipated to garner a share/size of 54.0% during 2025-2037.

The North America infection surveillance solutions sector is poised to hold 34.5% share by the end of 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample